Dr. Shah Discusses Ongoing Research With CAR T-Cell Therapy

Video

Nirav N. Shah, MD, assistant professor, Medical College of Wisconsin, discusses ongoing research with CAR T-cell therapy.

Nirav N. Shah, MD, assistant professor, Medical College of Wisconsin, discusses ongoing research with CAR T-cell therapy.

There are many studies evaluating future applications of CAR T cells and other cellular therapies, Shah says. There are armored CAR T cells being studied; these differ from the products currently on the market and may prove to be more effective, says Shah. In addition, ongoing research is looking at dual-targeted CAR T cells as well as sequential CAR T-cell therapy.

Moreover, some institutions are studying the role of a different type of immune effector cell called an NK cell. CAR NK is a construct that researchers hope is on the rise as another potential option for patients who have failed traditional treatments, Shah adds.

Recent Videos
Shahzad Raza, MD, a hematologist/oncologist at the Cleveland Clinic
Manali Kamdar, MD, the associate professor of medicine–hematology and clinical director of lymphoma services at the University of Colorado
Shahzad Raza, MD, a hematologist/oncologist at the Cleveland Clinic
Laura Aguilar MD, PhD, the chief medical officer of Diakonos Oncology
Jamie Jacobs, PhD, the program director of the center for psychiatric oncology & behavioral sciences at Mass General Cancer Center
Laura Aguilar MD, PhD, the chief medical officer of Diakonos Oncology
Sarah Hein, PhD, the chief executive officer and cofounder of March Biosciences
Brian Kim, MBA, the chief executive officer of Mission Bio
Peter Cook, PhD, a senior research scientist at Seattle Children’s Research Institute
Nicholas Giovannone, PhD, a senior principal scientist at Regeneron
Related Content
© 2025 MJH Life Sciences

All rights reserved.